Filter
3471
Filtered Results: 3471
Text search:
adverse
health
effects
Featured
Recommendations
361
New Publications
872
Language
Document type
No document type
1915
Studies & Reports
573
Guidelines
559
Manuals
182
Strategic & Response Plan
103
Fact sheets
60
Training Material
44
Situation Updates
16
Infographics
7
Resource Platforms
6
Brochures
3
Videos
2
App
1
Countries / Regions
India
178
Global
138
Kenya
81
South Africa
77
Western and Central Europe
76
Ethiopia
67
Nepal
61
Nigeria
57
Uganda
54
Latin America and the Carribbean
51
Africa
50
Sierra Leone
42
Tanzania
42
Ghana
41
Zambia
40
Malawi
37
Bangladesh
35
Myanmar / Burma
35
Liberia
34
Philippines
32
Ukraine
28
Rwanda
27
Zimbabwe
23
South–East Asia Region
23
Brazil
21
Cambodia
20
Eastern Europe
20
Namibia
20
Syria
19
Indonesia
19
East and Southern Africa
18
Mozambique
15
Asia
15
USA
14
South Sudan
14
Eswatini/ Swaziland
14
Guinea
13
West and Central Africa
13
Middle East and North Africa
13
Botswana
13
Eastern Europe and Central Asia
12
Lesotho
11
Germany
11
Senegal
10
Congo, Democratic Republic of
10
Russia
10
Thailand
9
Sudan
9
Burkina Faso
8
Western Pacific Region
8
Colombia
7
Venezuela
7
Yemen
7
Pakistan
7
Afghanistan
6
Moldova
6
Jordan
5
Lebanon
5
China
4
Chile
4
Laos
4
Haiti
4
Paraguay
4
Sri Lanka
4
Mali
4
Angola
4
Somalia
4
Tajikistan
3
Timor Leste/ East Timor
3
Benin
3
Cameroon
3
Niger
3
Argentina
3
Vietnam
3
Egypt
3
Bhutan
3
Ecuador
3
Madagascar
3
North Macedonia
2
El Salvador
2
Gambia
2
Singapore
2
Kyrgyzstan
2
Guinea-Bissau
2
United Kingdom
2
Belarus
2
Palestine
2
Georgia
2
Central African Republic
2
Iraq
2
North Korea
1
Australia
1
Kazakhstan
1
Iran
1
Albania
1
Canada
1
Fiji
1
Burundi
1
Peru
1
Vanuatu
1
Mauritania
1
Lithuania
1
Ireland
1
North America
1
Turkmenistan
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Papua New Guinea
1
Djibouti
1
Romania
1
Greece
1
Poland
1
Honduras
1
Chad
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1112
Clinical Guidelines
388
Public Health
208
Women & Child Health
201
Key Resources
148
Capacity Building
52
Pharmacy & Technologies
33
Toolboxes
Mental Health
366
COVID-19
290
HIV
225
TB
223
Planetary Health
194
Pharmacy
113
NCDs
97
AMR
97
Caregiver
88
NTDs
86
Rapid Response
84
Conflict
74
Ebola
67
Global Health Education
65
Disability
60
Refugee
57
Natural Hazards
39
Specific Hazards
37
Zika
24
Health Financing Toolbox
18
Cholera
17
Polio
17
Social Ethics
7
Typhoon
2
21 August 2020
This guidance provides specific considerations for the use of non-medical masks, also known as fabric masks, by children as a means for source control in the context of the current COVID-19 pandemic. It also advises on the use of medical masks for children under certain conditions.
Web annex 5: Oxytocin and ergometrine versus placebo or no treatment
Evidence to decision framework
As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. I...
This document provides guidance on how to implement contact screening and chemoprophylaxis with single-dose rifampicin. The contents are logically ordered: counselling and obtaining consent, identification and listing of index case, listing of contacts, tracing of contacts, screening of contacts, ad...
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
This report summarizes the results of a 2018 survey of food and beverage marketing to children via television in the Kyrgyz Republic. It explores the extent and nature of children’s exposure to marketing for food high in saturated fat, free sugars and/or salt via television in the country. The stu...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
Manufacturers:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
Efficacy shown in clinical trials in participants who received the full series of vaccine (2 doses) ir...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...
The WHO operational handbook on tuberculosis: tuberculosis preventive treatment is the companion, implementation guide to the 2020 WHO guidelines on TB preventive treatment.[1] Just as these guidelines are the first to be released under the rubric of the WHO consolidated TB guidelines, this handbook...
COVID-19: occupational health and safety for health workers: interim guidance, Interim guidance 2 February 2021
Health workers are at the front line of the COVID-19 outbreak response and as such are exposed to different hazards that put them at risk. Occupational hazards include exposure to SARS-C...
13 July 2021
The module provides an overview of factors to consider when monitoring the safety of COVID-19 vaccines administered to pregnant and breastfeeding women. It describes how national routine AEFI surveillance should be adapted to cater for this specific group of population using both pass...
When situations occur in which unwanted events are rightly or wrongly connected with vaccination, they may erode confidence in vaccines and the authorities delivering them. This document presents the scientific evidence behind WHO’s recommendations on building and restoring confidence in vaccines ...
Health Care Facilities (HCFs) are primarily responsible for management of the healthcare waste generated within the facilities, including activities undertaken by them in the community. The health care facilities, while generating the waste are responsible for segregation, collection, in-house trans...
Since the launch of the 2012–2020 World Health Organization (WHO) road map for the control, elim-ination and eradication of neglected tropical diseases (NTDs) (1), considerable progress against NTDs has been made. Between 2010 and 2020, the number of people requiring interventions against NTDs glo...
As a Frontline Health Care Worker or a Vaccinator, you need to counsel pregnant women about the availability, value and precautions regarding the COVID-19 vaccine. This note provides you with the information that you need to educate and support pregnant women so that they can make an informed decisi...
